
Dr. Reddy’s Laboratories
Integrated global pharmaceutical company.
- Healthcare
Get premium to view all results
Date | Investors | Amount | Round |
---|---|---|---|
N/A | €0.0 | round | |
investor | €0.0 | round | |
investor | €0.0 | round | |
* | $3.4m | Post IPO Equity | |
Total Funding | 000k |
INR | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|---|---|
Revenues | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
% growth | 13 % | 15 % | 14 % | 17 % | 9 % | (1 %) | 7 % |
EBITDA | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
% EBITDA margin | 25 % | 31 % | 30 % | 28 % | 26 % | 22 % | 23 % |
Profit | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
% profit margin | 11 % | 18 % | 20 % | 17 % | 17 % | 14 % | 14 % |
EV | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
EV / revenue | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
EV / EBITDA | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
R&D budget | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
R&D % of revenue | 8 % | 8 % | 8 % | 8 % | - | - | - |
Source: Company filings or news article, Equity research estimates
Analytics
Unlock the full power of analytics with a premium account
Track company size and historic growth
Track team composition and strength
Track website visits and app downloads
Tech stack
Tech stackLearn more about the technologies and tools that this company uses.
Investments by Dr. Reddy’s Laboratories
Edit
ACQUISITION by Dr. Reddy’s Laboratories Nov 2015
ACQUISITION by Dr. Reddy’s Laboratories Oct 2012

ACQUISITION by Dr. Reddy’s Laboratories Jan 2024

ACQUISITION by Dr. Reddy’s Laboratories Feb 2022